Catalent Pharma Solutions is upgrading a Japanese plant to offer clinical supply services, extending its global network of depots.
The Catalent Pharma Solutions facility in Morrisville, NC, where the company manufactures inhalation products, was written up with a half-dozen observations during a routine visit back in March, according to the Form 483 that the FDA posted publicly recently.
Drug developer Catalent Pharma Solutions is continuing its expansion in the Asia-Pacific region with the acquisition of a packaging company in Australia.
Catalent has signed a deal to lend its biologics development technology to China's Zhejiang Hisun Pharmaceuticals and help the drugmaker get working on copies of some top-selling drugs.
Catalent Pharma Solutions has been steadily expanding its manufacturing capabilities around the world and is now set to beef up in the center of the U.S. The move will add more than 230 jobs to its operation in Kansas City, MO.
Contract manufacturer Catalent Pharma Solutions is expanding again, this time at a controlled release drug manufacturing facility in Winchester, KY, with a little help from that state.
More and more companies are looking for the best way to capture a piece of the expanding Chinese market, and Catalent Pharma Solutions intends to be among them. It has nailed down two deals that will give it manufacturing capacity there.
Catalent Pharma Solutions is betting big on the Chinese market, launching two joint ventures for its Softgel Technologies and Clinical Supply Solutions businesses.
Catalent Pharma Solutions is again expanding its manufacturing operations in North Carolina, this time to build new capacity for inhalation drugs.
Catalent Pharma Solutions says the demand for products at its plant in Swindon, U.K., is "changing," and so it is reducing head count there by nearly four dozen employees.